Strs Ohio Verve Therapeutics, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$8.84 - $18.7 $8,840 - $18,700	1,000 New	1,000 $13,000
Q3 2022 Oct 27, 2022	BUY	$15.63 - $41.49 $110,973 - $294,579	7,100 New	7,100 $243,000
Q2 2022 Jul 25, 2022	SELL	$11.14 - $23.17 $95,804 - $199,262	-8,600 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$20.92 - $39.36 $104,600 - $196,800	5,000 Added 138.89%	8,600 $196,000
Q3 2021 Oct 22, 2021	BUY	$46.0 - $73.99 $165,600 - $266,364	3,600 New	3,600 $169,000

186

73.3M

85K

215K

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $291M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.